ibandronic acid has been researched along with taurine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chawla, PS; Kochar, MS | 1 |
| Binder, M; Dieterle, F; Ross, A; Schlotterbeck, G; Senn, H; Suter, L | 1 |
1 review(s) available for ibandronic acid and taurine
| Article | Year |
|---|---|
What's new in clinical pharmacology and therapeutics.
Topics: Acamprosate; Amyloid; Azabicyclo Compounds; Daptomycin; Diphosphonates; Drug Approval; Humans; Ibandronic Acid; Influenza Vaccines; Islet Amyloid Polypeptide; Ketolides; Lanthanum; Memantine; Pharmacology, Clinical; Piperazines; Rifamycins; Rifaximin; Scopolamine Derivatives; Taurine; Tiotropium Bromide; United States; United States Food and Drug Administration | 2006 |
1 other study(ies) available for ibandronic acid and taurine
| Article | Year |
|---|---|
Application of metabonomics in a comparative profiling study reveals N-acetylfelinine excretion as a biomarker for inhibition of the farnesyl pathway by bisphosphonates.
Topics: Animals; Biomarkers; Creatine; Cysteine; Diphosphonates; Geranyltranstransferase; Glucose; Ibandronic Acid; Imidazoles; Molecular Structure; Prenylation; Rats; Signal Transduction; Taurine; Zoledronic Acid | 2007 |